IRON AMINOS GLP-3 RETA 50MG
Research-grade incretin-pathway material prepared for consistency and clear documentation in professional lab workflows.
Key Features
50mg GLP-3 RETA per vial (lyophilized powder)
≥99% purity for reproducible results
Sterile, sealed glass vial with tamper-evident flip cap
Lot and batch labeling for traceability
Diluent not included
Specifications
Compound: GLP-3 RETA
Class: Triple receptor agonist research category (GLP-1, GIP, glucagon)
Form / appearance: Lyophilized powder, white to off-white
Amount: 50mg per vial
Purity: ≥99%
Storage (lyophilized): Cool, dry, away from light
Storage (after reconstitution): Refrigerate, use promptly per internal SOP
What’s Included
1 × GLP-3 RETA 50mg vial (no diluent)
Handling
Use an appropriate sterile diluent and aseptic technique. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.
Research Snapshot
Triple-agonist compounds in this class have demonstrated substantial body-weight reductions in randomized research settings when paired with dietary control and structured dose escalation.
In type 2 diabetes research models, this class has shown meaningful HbA1c reductions alongside weight effects and improvements in selected metabolic markers.
Common study-reported adverse events are gastrointestinal, including nausea, vomiting, and diarrhea, and are typically dose dependent. Gradual titration is often used to improve tolerability.
GLP-3 RETA is investigational and supplied strictly for laboratory research. Outcomes vary by model, protocol, and exposure conditions.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
